Adaptive Biotechnologies, Facebook, Tesla and more


Chad Robins, CEO of Adaptive Biotechnologies.

Anjali Sundaram | CNBC

Check out the companies making headlines after the bell.

Adaptive Biotechnologies – The biotechnology company’s stock fell 5% in extended trading after Adaptive gave its first-quarter financial results. The company reported a loss of 25 cents per share on revenue of $20.9 million, while analysts polled by Refinitiv expected a loss of 20 cents per share with revenue of $21.5 million.

Facebook – The social media giant’s stock dipped 1% after the closing bell. Law firm Burns Charest announced Tuesday that it was seeking approval of a $52 million class-action

Read More